Literature DB >> 1904065

The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal.

N Quarto1, F P Finger, D B Rifkin.   

Abstract

Basic fibroblast growth factor (bFGF) is a member of the heparin-binding growth factor (HBGF) family that includes at least seven species. These proteins are potent regulators of a number of cellular processes, including cell division and angiogenesis. Multiple forms of bFGF exist differing only in the length of their NH2-terminal extensions. These species of bFGF also have unique subcellular distributions. The smallest form (18 kD) occurs predominantly in the cytosol, while the higher molecular weight forms (22, 22.5, 24 kD) are associated with the nucleus and ribosomes. Here we report that the nuclear localization of the higher molecular weight forms of bFGF derives specifically from the amino acid sequences within the NH2-terminal extension. This has been demonstrated by constructing a chimeric protein containing the NH2-terminal extension of the highest molecular weight form of bFGF fused to beta-galactosidase (beta-gal). After transfection in a transient expression system, the chimeric protein accumulated in the nuclei of transfected cells, while the wild-type beta-gal was found predominantly in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904065     DOI: 10.1002/jcp.1041470217

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  38 in total

1.  Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals.

Authors:  M Arese; Y Chen; R Z Florkiewicz; A Gualandris; B Shen; D B Rifkin
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

Review 2.  Signaling by fibroblast growth factors: the inside story.

Authors:  M Goldfarb
Journal:  Sci STKE       Date:  2001-10-30

Review 3.  Molecular aspects of pathological processes in the artery wall.

Authors:  J W van Neck; H P Bloemers
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

4.  Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering.

Authors:  Natalina Quarto; Björn Behr; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

5.  High molecular weight FGF2 isoforms demonstrate canonical receptor-mediated activity and support human embryonic stem cell self-renewal.

Authors:  Denis Kole; Alexandra Grella; David Dolivo; Lucia Shumaker; William Hermans; Tanja Dominko
Journal:  Stem Cell Res       Date:  2017-04-18       Impact factor: 2.020

Review 6.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

7.  High levels of CUG-initiated FGF-2 expression cause chromatin compaction, decreased cardiomyocyte mitosis, and cell death.

Authors:  Cheryl J A Hirst; Meenhard Herlyn; Peter A Cattini; Elissavet Kardami
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

8.  Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.

Authors:  Jedrzej Małecki; Jørgen Wesche; Camilla Skiple Skjerpen; Antoni Wiedłocha; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

9.  Fgf-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss.

Authors:  Silvia Zucchini; Andrea Buzzi; Mario Barbieri; Donata Rodi; Beatrice Paradiso; Anna Binaschi; J Douglas Coffin; Andrea Marzola; Pierangelo Cifelli; Ottorino Belluzzi; Michele Simonato
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

10.  Cytokine-induced selective increase of high-molecular-weight bFGF isoforms and their subcellular kinetics in cultured rat hippocampal astrocytes.

Authors:  H Kamiguchi; K Yoshida; H Wakamoto; M Inaba; H Sasaki; M Otani; S Toya
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.